A review of clinical experience with paclitaxel extravasations

Supportive Care in Cancer

Volumn 11, Issue 5, 2003, Pages 270-277

  Stanford, Brad L ^a   Hardwicke, Fred ^b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

Extravasation; Hyaluronidase; Paclitaxel; Recall reaction; Vesicant

Indexed keywords

PACLITAXEL;

ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; DRUG EFFICACY; DRUG EXTRAVASATION; DRUG SAFETY; EDEMA; ERYTHEMA; HUMAN; INFLAMMATION; NECROSIS; OVARY CARCINOMA; PAIN; PHLEBITIS; PRIORITY JOURNAL; PRURITUS; REVIEW; ULCER;

EID: 0038274781     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-003-0441-0     Document Type: Review

References (37)

1. Ajani JA, Dodd LG, Daugherty K, Warkentin D, Ilson DH (1994) Taxol-induced soft-tissue injury secondary to extravasation: characterization by histopathology and clinical course. J Natl Cancer Inst 86:51-53
2. Alberts DS, Dorr RT (1991) Case report: topical DMSO for mitomycin-C-induced skin ulceration. Oncol Nurs Forum 18:693-695
3. Argenta LC, Manders EK (1983) Mitomycin C extravasation injuries. Cancer 51:1080-1082
4. Bailey WL, Crump RM (1997) Taxol extravasation: A case report. Can Oncol Nurs J 7:97-99
5. Barutca S, Kadikoylu G, Bolaman Z, Meydan N, Yavasoglu I (2002) Extravasation of paclitaxel into breast tissue from central catheter port. Support Care Cancer 10:563-565
6. Berghmans T, Klastersky J (1995) Paclitaxel-induced cutaneous toxicity. Support Care Cancer 3:203-204
7. Bertelli G, Dini D, Forno GB, Gozza A, Silvestro S, Venturini M, Rosso R, Pronzato P (1994) Hyaluronidase as an antidote to extravasation of Vinca alkaloids: clinical results. J Cancer Res Clin Oncol 120:505-506
8. Bertelli G, Cafferata MA, Ardizzoni A, Gozza A, Rosso R, Dini D (1997) Skin ulceration potential of paclitaxel in a mouse skin model in vivo (letter). Cancer 79:2266-2268
9. Bicher A, Levenback C, Burke TW, Morris M, Warner D, DeJesus Y, Gershenson DM (1995) Infusion site soft-tissue injury after paclitaxel administration. Cancer 76:116-120
10. Boyle DM, Engelking C (1995) Vesicant extravasation: myths and realities. Oncol Nurs Forum 22:57-67
11. Brothers TE, Moll LK, Miederhuber JE, Roberts JA, Walker-Andrews S, Ensminger WD (1988) Experience with subcutaneous infusion ports in three hundred patients. Surg Gynecol Obstet 166:295-301
12. Brown J, McDermott B, Runzer N (1992) Taxol: women with ovarian cancer participate in a new clinical trial. Can Oncol Nurs J 2:47-50
13. Dorr RT, Alberts DS (1983) Skin ulceration potential without therapeutic anticancer activity for epipodophyllotoxin commercial diluents. Invest New Drugs 1:151-159
14. Dorr RT, Snead K, Liddil JD (1996) Skin ulceration potential of paclitaxel in a mouse skin model in vivo. Cancer 78:152-156
15. Du Bois A, Fehr MK, Bochtler H, Koechli OR (1996) Clinical course and management of paclitaxel extravasation. Oncol Rep 3:973-974
16. Du Bois A, Kommoss FGM, Pfisterer J, Lück HJ, Meerpohl HG (1996) Paclitaxel-induced "recall" soft tissue ulcerations occurring at the site of previous subcutaneous administration of paclitaxel in low doses. Gynecol Oncol 60:94-96
17. Goodman M, Stewart I, Lydon J, Blendowski C, Barnicle M, Petersen J, Wickham R (1996) Use caution when managing paclitaxel and Taxotere infiltrations (letter). Oncol Nurs Forum 23:541-542
18. Greco FA, Brereton HD, Kent H, Zimbler H, Merrill J, Johnson RE (1976) Adriamycin and enhanced radiation reaction in normal esophagus and skin. Ann Intern Med 85:294-298
19. Herrington JD, Figueroa JA (1997) Severe necrosis due to paclitaxel extravasation. Pharmacotherapy 17:163-165
20. Hidalgo M, Benito J, Colomer R, Paz-Ares L (1996) Recall reaction of a severe local peripheral neuropathy after paclitaxel extravasation (letter). J Natl Cancer Inst 88:1320
21. Ignoffo RJ, Friedman MA (1980) Therapy of local toxicities caused by extravasation of cancer chemotherapeutic drugs. Cancer Treat Rev 7:17-27
22. Larson DL (1982) Treatment of tissue extravasation by antitumor agents. Cancer 49:1796-1799
23. Link CJ, Sarosy GA, Kohn EC, Christian MC, Davis P, Adamo DO, Reed E (1995) Cutaneous manifestations of Taxol therapy. Invest New Drugs 13:261-263
24. Lubejko BG, Sartorius SE (1993) Nursing considerations in paclitaxel (Taxol) administration. Semin Oncol 20(suppl 3):26-30
25. Maroko PR, Hillis LD, Muller JE, Tavazzi L, Heyndrickx GR, Ray M, Chiariello M, Distante A, Askenazi J, Salerno J, Carpentier J, Reshetnaya NI, Radvany P, Libby P, Raabe DS, Chazov EI, Bobba P, Braunwald E (1977) Favorable effects of hyaluronidase on electrocardiographic evidence of necrosis in patients with acute myocardial infarction. N Engl J Med 296:898-903
26. Meehan JL, Sporn JR (1994) Case report of taxol administration via central vein producing a recall reaction at a site of prior taxol extravasation. J Natl Cancer Inst 86:1250-1251
27. Noone MH, McCabe MS, Denicoff AM, Lepore JM (1993) Nursing management of the patient receiving Taxol therapy. J Natl Cancer Inst Monogr 15:149-154
28. Oncology Nursing Society (2002) Cancer chemotherapy and biotherapy guidelines and recommendations for practice: module XXII. Oncology Nursing Press, Pittsburgh
29. Phillips KA, Urch M, Bishop JF (1995) Radiation-recall dermatitis in a patient treated with paclitaxel (letter). J Clin Oncol 13:305
30. Raghavan VT, Bloomer WD, Merkel DE (1993) Taxol and radiation recall dermatitis (letter). Lancet 341:1354
31. Raymond E, Cartier S, Canuel C, Louvet C, Demeynck B, Debray M, Varette C, Baux S, Mimoun M, Gramont A de, Krulik M (1995) Extravasation de paclitaxel (Taxol). Rev Med Interne 16:141-142
32. Rogers BB (1993) Nursing implications in the administration of paclitaxel (Taxol). Semin Oncol Nurs 9(suppl 2):11-15
33. Rowinsky EK, Donehower RC (1995) Paclitaxel. N Engl J Med 332:1004-1014
34. Rowinsky EK, Eisenhauer EA, Chaudhry V, Arbuck SG, Donehower RC (1993) Clinical toxicities encountered with paclitaxel (Taxol). Semin Oncol 20(suppl 3):1-15
35. Shapiro J, Richardson GE (1994) Paclitaxel-induced "recall" soft tissue injury occurring at the site of previous extravasation with subsequent intravenous treatment in a different limb (letter). J Clin Oncol 12:2237-2238
36. Shenkier T, Gelmon K (1994) Paclitaxel and radiation-recall dermatitis (letter). J Clin Oncol 12:439
37. Stein ME, Drumea K, Abu-Rasmi R, Haim N (1997) Taxol-induced cellulites after extravasation: A rarely reported event (letter). Am J Clin Oncol 20:540